Skip to main content
Raul Silva, MD, Psychiatry, Cresskill, NJ, Englewood Health

RaulRSilvaMD

Psychiatry Cresskill, NJ

Child & Adolescent Psychiatry

Physician

Dr. Silva is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Silva's full profile

Already have an account?

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Child and Adolescent Psychiatry, 1990 - 1992
  • Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital Center
    Icahn School of Medicine at Mount Sinai/St Luke’s-Roosevelt Hospital CenterFellowship, Child and Adolescent Psychiatry, 1988 - 1990
  • Richmond University Medical Center
    Richmond University Medical CenterResidency, Psychiatry, 1984 - 1988
  • Ross University School of Medicine
    Ross University School of MedicineClass of 1983

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2007 - 2025
  • NY State Medical License
    NY State Medical License 1989 - 2017
  • American Board of Psychiatry and Neurology Psychiatry
  • American Board of Psychiatry and Neurology Child & Adolescent Psychiatry

Awards, Honors, & Recognition

  • Top Doctors: New York Metro Area Castle Connolly, 2012-2014

Publications & Presentations

PubMed

Press Mentions

  • Cingulate Announces Positive Fed/Fast Study Results of CTx-1301 ADHD Lead Asset
    Cingulate Announces Positive Fed/Fast Study Results of CTx-1301 ADHD Lead AssetFebruary 23rd, 2023
  • Cingulate Completes Phase 3 Adult Trial of CTx-1301 (Dexmethylphenidate) for ADHD
    Cingulate Completes Phase 3 Adult Trial of CTx-1301 (Dexmethylphenidate) for ADHDJune 9th, 2023
  • Cingulate Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of ...
    Cingulate Announces Detailed Trial Results from Phase 3 Adult Efficacy and Safety Trial of ...September 12th, 2023

Hospital Affiliations